0001104659-14-041402.txt : 20140523
0001104659-14-041402.hdr.sgml : 20140523
20140523160026
ACCESSION NUMBER: 0001104659-14-041402
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140514
FILED AS OF DATE: 20140523
DATE AS OF CHANGE: 20140523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fibrocell Science, Inc.
CENTRAL INDEX KEY: 0000357097
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870458888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 484-713-6000
MAIL ADDRESS:
STREET 1: 405 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: ISOLAGEN INC
DATE OF NAME CHANGE: 20020320
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE
DATE OF NAME CHANGE: 19960330
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO
DATE OF NAME CHANGE: 19921008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maslowski John Michael
CENTRAL INDEX KEY: 0001608774
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31564
FILM NUMBER: 14867192
MAIL ADDRESS:
STREET 1: 404 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
3
1
a3.xml
3
X0206
3
2014-05-14
0
0000357097
Fibrocell Science, Inc.
FCSC
0001608774
Maslowski John Michael
405 EAGLEVIEW BOULEVARD
EXTON
PA
19341
0
1
0
0
V.P., Scientific Affairs
Common Stock
480
D
Option to Purchase Common Stock
18.75
2019-10-06
Common Stock
4000
D
Option to Purchase Common Stock
15.50
2021-01-14
Common Stock
13600
D
Option to Purchase Common Stock
5.49
2023-07-19
Common Stock
17500
D
Option to Purchase Common Stock
4.95
2024-01-17
Common Stock
20000
D
Option to Purchase Common Stock
2.94
2024-05-13
Common Stock
20000
D
Warrant to Purchase Common Stock
6.25
2011-01-21
2016-12-31
Common Stock
960
D
50% of the Option to Purchase Common Stock vested on October 6, 2010 and 50% of the Option to Purchase Common Stock vested on the date the Issuer received approval for azficel-T.
50% of the Option to Purchase Common Stock vested on January 14, 2011, 25% of the Option to Purchase Common Stock vested on January 14, 2012 and 25% of the Option to Purchase Common Stock vested on January 14, 2013.
25% of the Option to Purchase Common Stock vested on July 19, 2013, 25% of the Option to Purchase Common Stock will vest on July 19, 2014, 25% of the Option to Purchase Common Stock will vest on July 19, 2015 and 25% of the Option to Purchase Common Stock will vest on July 19, 2016; in each case provided the reporting person is providing services to the Issuer on each vesting date.
25% of the Option to Purchase Common Stock will vest on January 17, 2015, 25% of the Option to Purchase Common Stock will vest on January 17, 2016, 25% of the Option to Purchase Common Stock will vest on January 17, 2017, and 25% of the Option to Purchase Common Stock will vest on January 17, 2018; in each case provided the reporting person is providing services to the Issuer on each vesting date.
25% of the Option to Purchase Common Stock will vest on May 13, 2015, 25% of the Option to Purchase Common Stock will vest on May 13, 2016, 25% of the Option to Purchase Common Stock will vest on May 13, 2017, and 25% of the Option to Purchase Common Stock will vest on May 13, 2018; in each case provided the reporting person is providing services to the Issuer on each vesting date.
/s/ John Maslowski
2014-05-23